-
1
-
-
77955273537
-
-
Lyon, France, International Agency for Research on Cancer
-
Ferlay J, Shin HR, Bray F, et al: GLOBOCAN 2008: Cancer Incidence and Mortality Worldwide-IARC CancerBase No. 10. Lyon, France, International Agency for Research on Cancer, 2010. http://globocan.iarc.fr
-
(2010)
GLOBOCAN 2008: Cancer Incidence and Mortality Worldwide-IARC CancerBase No. 10
-
-
Ferlay, J.1
Shin, H.R.2
Bray, F.3
-
2
-
-
25644461068
-
International lung cancer trends by histologic type: Male:female differences diminishing and adenocarcinoma rates rising
-
DOI 10.1002/ijc.21183
-
Devesa SS, Bray F, Vizcaino AP, et al: International lung cancer trends by histologic type: Male: female differences diminishing and adenocarcinoma rising. Int J Cancer 117:294-299, 2005 (Pubitemid 41379403)
-
(2005)
International Journal of Cancer
, vol.117
, Issue.2
, pp. 294-299
-
-
Devesa, S.S.1
Bray, F.2
Vizcaino, A.P.3
Parkin, D.M.4
-
3
-
-
45349096041
-
-
American Cancer Society. Atlanta, GA, American Cancer Society
-
American Cancer Society: Cancer Facts and Figures 2008. Atlanta, GA, American Cancer Society, 2008
-
(2008)
Cancer Facts and Figures 2008
-
-
-
4
-
-
77950520452
-
Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: Two metaanalyses of individual patient data
-
NSCLC Meta-analyses Collaborative Group
-
NSCLC Meta-analyses Collaborative Group, Arriagada R, Auperin A, et al: Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: Two metaanalyses of individual patient data. Lancet 375:1267-1277, 2010
-
(2010)
Lancet
, vol.375
, pp. 1267-1277
-
-
Arriagada, R.1
Auperin, A.2
-
5
-
-
75749145931
-
Management of patients with advanced non-small cell lung cancer: Current and emerging options
-
Triano LR, Deshpande H, Gettinger SN: Management of patients with advanced non-small cell lung cancer: Current and emerging options. Drugs 70:167-179, 2010
-
(2010)
Drugs
, vol.70
, pp. 167-179
-
-
Triano, L.R.1
Deshpande, H.2
Gettinger, S.N.3
-
6
-
-
62549108221
-
Toxicity of targeted therapy in non-small-cell lung cancer management
-
Ricciardi S, Tomao S, de Marinis F: Toxicity of targeted therapy in non-small-cell lung cancer management. Clin Lung Cancer 10:28-35, 2009
-
(2009)
Clin Lung Cancer
, vol.10
, pp. 28-35
-
-
Ricciardi, S.1
Tomao, S.2
De Marinis, F.3
-
7
-
-
36048995250
-
Patientreported outcomes to support medical product labeling claims: FDA perspective
-
Patrick DL, Burke LB, Powers JH, et al: Patientreported outcomes to support medical product labeling claims: FDA perspective. Value Health 2:215-237, 2007
-
(2007)
Value Health
, vol.2
, pp. 215-237
-
-
Patrick, D.L.1
Burke, L.B.2
Powers, J.H.3
-
8
-
-
0142121284
-
Beyond the development of health-related quality-of-life (HRQOL) measures: A checklist for evaluating HRQOL outcomes in cancer clinical trials - Does HRQOL evaluation in prostate cancer research inform clinical decision making?
-
DOI 10.1200/JCO.2003.12.121
-
Efficace F, Bottomley A, Osoba D, et al: Beyond the development of health-related quality of life (HRQOL) measures: A checklist for evaluation of HRQOL outcomes in cancer clinical trials-Does HRQOL evaluation in prostate cancer research inform clinical decision making? J Clin Oncol 21:3502-3511, 2003 (Pubitemid 46594084)
-
(2003)
Journal of Clinical Oncology
, vol.21
, Issue.18
, pp. 3502-3511
-
-
Efficace, F.1
Bottomley, A.2
Osoba, D.3
Gotay, C.4
Flechtner, H.5
D'Haese, S.6
Zurlo, A.7
-
9
-
-
0347285244
-
Methodological issues in assessing health-related quality of life of colorectal cancer patients in randomised controlled trials
-
DOI 10.1016/j.ejca.2003.10.012
-
Efficace F, Bottomley A, Vanvoorden V, et al: Methodological issues in assessing health-related quality of life of colorectal cancer patients in randomized controlled trials. Eur J Cancer 40:187-197, 2004 (Pubitemid 38077020)
-
(2004)
European Journal of Cancer
, vol.40
, Issue.2
, pp. 187-197
-
-
Efficace, F.1
Bottomley, A.2
Vanvoorden, V.3
Blazeby, J.M.4
-
10
-
-
34047138486
-
Has the quality of health-related quality of life reporting in cancer clinical trials improved over time? Towards bridging the gap with clinical decision making
-
DOI 10.1093/annonc/mdl494
-
Efficace F, Osoba D, Gotay C, et al: Has the quality of health-related quality of life reporting in cancer clinical trials improved over time? Towards bridging the gap with clinical decision making. Ann Oncol 18:775-781, 2007 (Pubitemid 46523284)
-
(2007)
Annals of Oncology
, vol.18
, Issue.4
, pp. 775-781
-
-
Efficace, F.1
Osoba, D.2
Gotay, C.3
Sprangers, M.4
Coens, C.5
Bottomley, A.6
-
11
-
-
77949449401
-
What changes in health-related quality of life matter to multiple myeloma patients? A prospective study
-
Kvam AK, Fayers P, Wisloff F: What changes in health-related quality of life matter to multiple myeloma patients? A prospective study. Eur J Haematol 84:345-353, 2010
-
(2010)
Eur J Haematol
, vol.84
, pp. 345-353
-
-
Kvam, A.K.1
Fayers, P.2
Wisloff, F.3
-
12
-
-
77954321859
-
Metastatic non-small-cell lung cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up
-
D'Addario G, Früh M, Reck M, et al: Metastatic non-small-cell lung cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 21:v116-v119, 2010 (suppl 5)
-
(2010)
Ann Oncol
, vol.21
, Issue.SUPPL. 5
-
-
D'addario, G.1
Früh, M.2
Reck, M.3
-
13
-
-
0042887522
-
Health-related quality of life in non-small-cell lung cancer: Methodologic issues in randomized controlled trials
-
DOI 10.1200/JCO.2003.01.203
-
Bottomley A, Efficace F, Thomas R, et al: Health-related quality of life in non-small-cell lung cancer: Methodologic issues in randomized controlled trials. J Clin Oncol 21:2982-2992, 2003 (Pubitemid 46621851)
-
(2003)
Journal of Clinical Oncology
, vol.21
, Issue.15
, pp. 2982-2992
-
-
Bottomley, A.1
Efficace, F.2
Thomas, R.3
Vanvoorden, V.4
Ahmedzai, S.H.5
-
14
-
-
0034772091
-
Clinical-benefit response in advanced non-small-cell lung cancer: A multicentre prospective randomised phase III study of single agent gemcitabine versus cisplatin-vindesine
-
DOI 10.1023/A:1012208711013
-
Vansteenkiste JF, Vandebroek JE, Nackaerts KL, et al: Clinical-benefit response in advanced nonsmall cell lung cancer: A randomized phase III study of single agent gemcitabine versus cisplatin-vindesine. Ann Oncol 12:1221-1230, 2001 (Pubitemid 32994749)
-
(2001)
Annals of Oncology
, vol.12
, Issue.9
, pp. 1221-1230
-
-
Vansteenkiste, J.F.1
Vandebroek, J.E.2
Nackaerts, K.L.3
Weynants, P.4
Valcke, Y.J.5
Verresen, D.A.6
Devogelaere, R.C.7
Marien, S.A.8
Humblet, Y.P.9
Dams, N.L.10
-
15
-
-
12444321554
-
Influence of cisplatin-use, age, performance status and duration of chemotherapy on symptom control in advanced non-small cell lung cancer: Detailed symptom analysis of a randomised study comparing cisplatin-vindesine to gemcitabine
-
DOI 10.1016/S0169-5002(02)00515-9, PII S0169500202005159
-
Vansteenkiste J, Vandebroek J, Nackaerts K, et al: Influence of cisplatin-use, age, performance status and duration of chemotherapy on symptom control in advanced non-small cell lung cancer: Detailed symptom analysis of a randomised study comparing cisplatin-vindesine to gemcitabine. Lung Cancer 40: 191-199, 2003 (Pubitemid 36438720)
-
(2003)
Lung Cancer
, vol.40
, Issue.2
, pp. 191-199
-
-
Vansteenkiste, J.1
Vandebroek, J.2
Nackaerts, K.3
Dooms, C.4
Galdermans, D.5
Bosquee, L.6
Delobbe, A.7
Deschepper, K.8
Van Kerckhoven, W.9
Vandeurzen, K.10
Deman, R.11
D'Odemont, J.-P.12
Siemons, L.13
Van Den Brande, P.14
Dams, N.15
-
16
-
-
0037206299
-
Immediate versus delayed palliative thoracic radiotherapy in patients with unresectable locally advanced non-small cell lung cancer and minimal thoracic symptoms: Results of a randomized controlled trial
-
Falk SJ, Girling DJ, White RJ, et al: Immediate versus delayed palliative thoracic radiotherapy in patients with unresectable locally advanced non-small cell lung cancer and minimal thoracic symptoms: Results of a randomized controlled trial. BMJ 325:465, 2002
-
(2002)
BMJ
, vol.325
, pp. 465
-
-
Falk, S.J.1
Girling, D.J.2
White, R.J.3
-
17
-
-
0036929352
-
GLOB-1: A prospective randomised clinical phase III trial comparing vinorelbine-cisplatin with vinorelbine-ifosfamide-cisplatin in metastatic non-small-cell lung cancer patients
-
DOI 10.1093/annonc/mdf316
-
Souquet PJ, Tan EH, Pereira RJ, et al:GLOB-1: A prospective randomised clinical phase III trial comparing vinorelbine-cisplatin with vinorelbineifosfamide-cisplatin in metastatic non-small-cell lung cancer patients. Ann Oncol 13:1853-1861, 2002 (Pubitemid 36040773)
-
(2002)
Annals of Oncology
, vol.13
, Issue.12
, pp. 1853-1861
-
-
Souquet, P.J.1
Tan, E.H.2
Rodrigues Pereira, J.3
Van Klaveren, R.4
Price, A.5
Gatzemeier, U.6
Jaworski, M.7
Burillon, J.P.8
Aubert, D.9
-
18
-
-
0037420202
-
Chemotherapy for elderly patients with advanced non-small-cell lung cancer: The multicenter Italian lung cancer in the elderly study (MILES) phase III randomized trial
-
Gridelli C, Perrone F, Gallo C, et al: Chemotherapy for elderly patients with advanced non-small-cell lung cancer: The Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial. J Natl Cancer Inst 95:362-372, 2003 (Pubitemid 36395256)
-
(2003)
Journal of the National Cancer Institute
, vol.95
, Issue.5
, pp. 362-372
-
-
Gridelli, C.1
Perrone, F.2
Gallo, C.3
Cigolari, S.4
Rossi, A.5
Piantedosi, F.6
Barbera, S.7
Ferrau, F.8
Piazza, E.9
Rosetti, F.10
Clerici, M.11
Bertetto, O.12
Robbiati, S.F.13
Frontini, L.14
Sacco, C.15
Castiglione, F.16
Favaretto, A.17
Novello, S.18
Migliorino, M.R.19
Gasparini, G.20
Galetta, D.21
Iaffaioli, R.V.22
Gebbia, V.23
Celano, A.24
Schiavon, S.25
Illiano, A.26
Raucci, C.A.27
Caruso, M.28
Foa, P.29
Tonini, G.30
Curcio, C.31
Cazzaniga, M.32
more..
-
19
-
-
0041912766
-
Gemcitabine plus vinorelbine compared with cisplatin plus vinorelbine or cisplatin plus gemcitabine for advanced non-small-cell lung cancer: A phase III trial of the Italian GEMVIN Investigators and the National Cancer Institute of Canada Clinical Trials Group
-
DOI 10.1200/JCO.2003.06.099
-
Gridelli C, Gallo C, Frances A, et al: Gemcitabine plus vinorelbine compared with cisplatin plus vinorelbine or cisplatin plus gemcitabine for advanced non-small cell lung cancer: A phase III trial of the Italian GEMVIN Investigators and the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 21:3025-3034, 2003 (Pubitemid 46606281)
-
(2003)
Journal of Clinical Oncology
, vol.21
, Issue.16
, pp. 3025-3034
-
-
Gridelli, C.1
Gallo, C.2
Shepherd, F.A.3
Illiano, A.4
Piantedosi, F.5
Robbiati, S.F.6
Manzione, L.7
Barbera, S.8
Frontini, L.9
Veltri, E.10
Findlay, B.11
Cigolari, S.12
Myers, R.13
Ianniello, G.P.14
Gebbia, V.15
Gasparini, G.16
Fava, S.17
Hirsh, V.18
Bezjak, A.19
Seymour, L.20
Perrone, F.21
more..
-
20
-
-
0042413836
-
Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: The TAX 326 Study Group
-
DOI 10.1200/JCO.2003.12.046
-
Fossella F, Pereira JR, von Pawel J, et al: Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: The TAX 326 study group. J Clin Oncol 21:3016-3024, 2003 (Pubitemid 46606280)
-
(2003)
Journal of Clinical Oncology
, vol.21
, Issue.16
, pp. 3016-3024
-
-
Fossella, F.1
Pereira, J.R.2
Von Pawel, J.3
Pluzanska, A.4
Gorbounova, V.5
Kaukel, E.6
Mattson, K.V.7
Ramlau, R.8
Szczesna, A.9
Fidias, P.10
Millward, M.11
Belani, C.P.12
-
21
-
-
33745893529
-
Effect of chemotherapy for advanced non-small cell lung cancer on patients' quality of life. A randomized controlled trial
-
DOI 10.1016/j.lungcan.2006.05.003, PII S0169500206002212
-
Belani CP, Pereira JR, von Pawel, et al: Effect of chemotherapy for advanced non-small cell lung cancer on patients' quality of life: A randomized controlled trial. Lung Cancer 53:231-239, 2006 (Pubitemid 44043122)
-
(2006)
Lung Cancer
, vol.53
, Issue.2
, pp. 231-239
-
-
Belani, C.P.1
Pereira, J.R.2
Von Pawel, J.3
Pluzanska, A.4
Gorbounova, V.5
Kaukel, E.6
Mattson, K.V.7
Ramlau, R.8
Szczesna, A.9
Fidias, P.10
Millward, M.11
Fossella, F.12
-
22
-
-
0242361194
-
First-line gemcitabine with cisplatin or epirubicin in advanced non-small-cell lung cancer: A phase III trial
-
DOI 10.1038/sj.bjc.6601283
-
Wachters FM, Van Putten JW, Kramer H, et al: First-line gemcitabine with cisplatin or epirubicin in advanced non-small-cell lung cancer: A phase III trial. Br J Cancer 89:1192-1199, 2003 (Pubitemid 37363401)
-
(2003)
British Journal of Cancer
, vol.89
, Issue.7
, pp. 1192-1199
-
-
Wachters, F.M.1
Van Putten, J.W.J.2
Kramer, H.3
Erjavec, Z.4
Eppinga, P.5
Strijbos, J.H.6
De Leede, G.P.J.7
Boezen, H.M.8
De Vries, E.G.E.9
Groen, H.J.M.10
-
23
-
-
0346560025
-
Three-arm randomized study of two cisplatin-based regimens and paclitaxel plus gemcitabine in advanced non-small-cell lung cancer: A phase III trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group - EORTC 08975
-
DOI 10.1200/JCO.2003.03.195
-
Smit EF, van Meerbeeck JP, Lianes P, et al: Three-arm randomized study of two cisplatin-based regimens and paclitaxel plus gemcitabine in advanced non-small-cell lung cancer: A phase III trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group-EORTC 08975. J Clin Oncol 21:3909-3917, 2003 (Pubitemid 46606203)
-
(2003)
Journal of Clinical Oncology
, vol.21
, Issue.21
, pp. 3909-3917
-
-
Smit, E.F.1
Van Meerbeeck, J.P.A.M.2
Lianes, P.3
Debruyne, C.4
Legrand, C.5
Schramel, F.6
Smit, H.7
Gaafar, R.8
Biesma, B.9
Manegold, C.10
Neymark, N.11
Giaccone, G.12
-
24
-
-
9144243571
-
Cisplatin versus carboplatin in combination with mitomycin and vinblastine in advanced non small cell lung cancer. A multicenter, randomized phase III trial
-
DOI 10.1016/S0169-5002(03)00280-0
-
Paccagnella A, Favaretto A, Oniga F, et al: Cisplatin versus carboplatin in combination with mitomycin and vinblastine in advanced non small cell lung cancer: A multicenter, randomized phase III trial. Lung Cancer 43:83-91, 2004 (Pubitemid 38096297)
-
(2004)
Lung Cancer
, vol.43
, Issue.1
, pp. 83-91
-
-
Paccagnella, A.1
Favaretto, A.2
Oniga, F.3
Barbieri, F.4
Ceresoli, G.5
Torri, W.6
Villa, E.7
Verusio, C.8
Cetto, G.L.9
Santo, A.10
De Pangher, V.11
Artioli, F.12
Cacciani, G.C.13
Parodi, G.14
Soresi, F.15
Ghi, M.G.16
Morabito, A.17
Biason, R.18
Giusto, M.19
Mosconi, P.20
Sileni, V.C.21
more..
-
25
-
-
1342332364
-
Phase III randomized trial of docetaxel plus cisplatin versus vindesine plus cisplatin in patients with stage IV non-small-cell lung cancer: The Japanese taxotere lung cancer study group
-
DOI 10.1200/JCO.2004.06.114
-
Kubota K, Watanabe K, Kunitoh H, et al: Phase III randomized trial of docetaxel plus cisplatin versus vindesine plus cisplatin in patients with stage IV nonsmall-cell lung cancer: The Japanese Taxotere Lung Cancer Study Group. J Clin Oncol 22:254-261, 2004 (Pubitemid 41095089)
-
(2004)
Journal of Clinical Oncology
, vol.22
, Issue.2
, pp. 254-261
-
-
Kubota, K.1
Watanabe, K.2
Kunitoh, H.3
Noda, K.4
Ichinose, Y.5
Katakami, N.6
Sugiura, T.7
Kawahara, M.8
Yokoyama, A.9
Yokota, S.10
Yoneda, S.11
Matsui, K.12
Kudo, S.13
Shibuya, M.14
Isobe, T.15
Segawa, Y.16
Nishiwaki, Y.17
Ohashi, Y.18
Niitani, H.19
-
26
-
-
11144354741
-
Continuously infused carboplatin used as radiosensitizer in locally unresectable non-small-cell lung cancer: A multicenter phase III study
-
DOI 10.1093/annonc/mdh100
-
Groen HJ, van der Leest AH, Fokkema E, et al: Continuously infused carboplatin used as radiosensitizer in locally unresectable non-small-cell lung cancer: A multicenter phase III study. Ann Oncol 15:427-432, 2004 (Pubitemid 38444545)
-
(2004)
Annals of Oncology
, vol.15
, Issue.3
, pp. 427-432
-
-
Groen, H.J.M.1
Van Der Leest, A.H.W.2
Fokkema, E.3
Timmer, P.R.4
Nossent, G.D.5
Smit, W.J.G.6
Nabers, J.7
Hoekstra, H.J.8
Hermans, J.9
Otter, R.10
Van Putten, J.W.G.11
De Vries, E.G.E.12
Mulder, N.H.13
-
27
-
-
3442886281
-
SRL 172 (killed Mycobacterium vaccae) in addition to standard chemotherapy improves quality of life without affecting survival, in patients with advanced non-small-cell lung cancer: Phase III results
-
DOI 10.1093/annonc/mdh220
-
O'Brien ME, Anderson H, Kaukel E, et al: SRL172 (killed Mycobacterium vaccae) in addition to standard chemotherapy improves quality of life without affecting survival, in patients with advanced non-small-cell lung cancer: Phase III results. Ann Oncol 15:906-914, 2004 (Pubitemid 39004346)
-
(2004)
Annals of Oncology
, vol.15
, Issue.6
, pp. 906-914
-
-
O'Brien, M.E.R.1
Anderson, H.2
Kaukel, E.3
O'Byrne, K.4
Pawlicki, M.5
Von Pawel, J.6
Reck, M.7
Ellis, P.8
Hickish, T.9
Nicolson, M.10
Woll, P.11
Dunlop, D.12
Falk, S.13
Johnson, P.14
Collinson, M.15
Hatton, M.16
Gilligan, D.17
Middleton, G.18
Reck, M.19
Loddenkemper, R.20
Deperman, K.21
Aigner, K.22
Pirker, R.23
Rothmund, J.24
Tujakowski, J.25
Krzakowski, M.26
Ramlau, R.27
Crawford, B.28
Massaro, J.29
Cross, A.30
Tuckwell, N.31
Kennard, D.32
Povey, J.33
more..
-
28
-
-
2942731677
-
Randomized phase III study of gemcitabine and vinorelbine versus gemcitabine, vinorelbine, and cisplatin in the treatment of advanced non-small-cell lung cancer: From the German and Swiss Lung Cancer Study Group
-
DOI 10.1200/JCO.2004.10.576
-
Laack E, Dickgreber N, Müller T, et al: Randomized phase III study of gemcitabine and vinorelbine versus gemcitabine, vinorelbine, and cisplatin in the treatment of advanced non-small-cell lung cancer: From the German and Swiss Lung Cancer Study Group. J Clin Oncol 22:2348-2356, 2004 (Pubitemid 41115391)
-
(2004)
Journal of Clinical Oncology
, vol.22
, Issue.12
, pp. 2348-2356
-
-
Laack, E.1
Dickgreber, N.2
Muller, T.3
Knuth, A.4
Benk, J.5
Lorenz, C.6
Gieseler, F.7
Durk, H.8
Engel-Riedel, W.9
Dalhoff, K.10
Kortsik, C.11
Graeven, U.12
Burk, M.13
Dierlanim, T.14
Welte, T.15
Burkholder, I.16
Edler, L.17
Hossfeld, D.K.18
-
29
-
-
4143146439
-
Front-line paclitaxel-vinorelbine versus paclitaxel-carboplatin in patients with advanced non-small-cell lung cancer: Arandomized phase III trial
-
DOI 10.1093/annonc/mdh260
-
Stathopoulos GP, Veslemes M, Georgatou N, et al: Front-line paclitaxel-vinorelbine versus paclitaxel-carboplatin in patients with advanced nonsmall-cell lung cancer: A randomized phase III trial. Ann Oncol 15:1048-1055, 2004 (Pubitemid 39089781)
-
(2004)
Annals of Oncology
, vol.15
, Issue.7
, pp. 1048-1055
-
-
Stathopoulos, G.P.1
Veslemes, M.2
Georgatou, N.3
Antoniou, D.4
Giamboudakis, P.5
Katis, K.6
Tsavdaridis, D.7
Rigatos, S.K.8
Dimitroulis, I.9
Bastani, S.10
Loukides, S.11
Vergos, K.12
Marossis, K.13
Grigoratou, T.14
Kalatzi, E.15
Charalambatou, M.16
Paspalli, A.17
Michalopoulou, P.18
Stoka, M.19
Gerogianni, A.20
more..
-
30
-
-
6344254442
-
Chemotherapy versus supportive care in advanced non-small cell lung cancer: Improved survival without detriment to quality of life
-
DOI 10.1136/thx.2003.020164
-
Spiro SG, Rudd RM, Souhami RL, et al: Chemotherapy versus supportive care in advanced nonsmall cell lung cancer: Improved survival without detriment to quality of life. Thorax 59:828-836, 2004 (Pubitemid 39389621)
-
(2004)
Thorax
, vol.59
, Issue.10
, pp. 828-836
-
-
Spiro, S.G.1
Rudd, R.M.2
Souhami, R.L.3
Brown, J.4
Fairlamb, D.J.5
Gower, N.H.6
Maslove, L.7
Milroy, R.8
Napp, V.9
Parmar, M.K.B.10
Peake, M.D.11
Stephens, R.J.12
Thorpe, H.13
Waller, D.A.14
West, P.15
-
31
-
-
34248591512
-
Closeness to Death and Quality of Life in Advanced Lung Cancer Patients
-
DOI 10.1016/j.clon.2007.02.008, PII S0936655507005225
-
Brown S, Thorpe H, Napp V, et al: Closeness to death and quality of life in advanced lung cancer patients. Clin Oncol (R Coll Radiol) 19:341-348, 2007 (Pubitemid 46760596)
-
(2007)
Clinical Oncology
, vol.19
, Issue.5
, pp. 341-348
-
-
Brown, S.1
Thorpe, H.2
Napp, V.3
Brown, J.4
-
32
-
-
12344334587
-
Phase II randomized trial of vinorelbine and gemcitabine versus carboplatin and paclitaxel in advanced non-small-cell lung cancer
-
DOI 10.1093/annonc/mdi009
-
Lilenbaum RC, Chen CS, Chidiac T, et al: Phase II randomized trial of vinorelbine and gemcitabine versus carboplatin and paclitaxel in advanced non-small-cell lung cancer. Ann Oncol 16:97-101, 2005 (Pubitemid 40124485)
-
(2005)
Annals of Oncology
, vol.16
, Issue.1
, pp. 97-101
-
-
Lilenbaum, R.C.1
Chen, C.-S.2
Chidiac, T.3
Schwarzenberger, P.O.4
Thant, M.5
Versola, M.6
Lane, S.R.7
-
33
-
-
16644398719
-
Gemcitabine plus carboplatin versus mitomycin, ifosfamide, and cisplatin in patients with stage IIIB or IV non-small-cell lung cancer: A phase III randomized study of the London Lung Cancer Group
-
DOI 10.1200/JCO.2005.03.037
-
Rudd RM, Gower NH, Spiro SG, et al: Gemcitabine plus carboplatin versus mitomycin, ifosfamide, and cisplatin in patients with stage IIIB or IV non-small-cell lung cancer: A phase III randomized study of the London Lung Cancer Group. J Clin Oncol 23:142-153, 2005 (Pubitemid 41702633)
-
(2005)
Journal of Clinical Oncology
, vol.23
, Issue.1
, pp. 142-153
-
-
Rudd, R.M.1
Gower, N.H.2
Spiro, S.G.3
Eisen, T.G.4
Harper, P.G.5
Littler, J.A.H.6
Hatton, M.7
Johnson, P.W.M.8
Martin, W.M.C.9
Rankin, E.M.10
James, L.E.11
Gregory, W.M.12
Qian, W.13
Lee, S.M.14
-
34
-
-
20244367173
-
Randomized phase II study of two gemcitabine schedules for patients with impaired performance status (Karnofsky performance status 70) and advanced non-small-cell lung cancer
-
DOI 10.1200/JCO.2005.01.003
-
Baka S, Ashcroft L, Anderson H, et al: Randomized phase II study of two gemcitabine schedules for patients with impaired performance status (Karnofsky performance status ≤ 70) and advanced non-small-cell lung cancer. J Clin Oncol 23:2136-2144, 2005 (Pubitemid 46218705)
-
(2005)
Journal of Clinical Oncology
, vol.23
, Issue.10
, pp. 2136-2144
-
-
Baka, S.1
Ashcroft, L.2
Anderson, H.3
Lind, M.4
Burt, P.5
Stout, R.6
Dowd, I.7
Smith, D.8
Lorigan, P.9
Thatcher, N.10
-
35
-
-
20244383481
-
Randomized trial of amifostine in locally advanced non-small-cell lung cancer patients receiving chemotherapy and hyperfractionated radiation: Radiation Therapy Oncology Group trial 98-01
-
DOI 10.1200/JCO.2005.07.167
-
Movsas B, Scott C, Langer C, et al: Randomized trial of amifostine in locally advanced non-smallcell lung cancer patients receiving chemotherapy and hyperfractionated radiation: Radiation therapy oncology group trial 98-01. J Clin Oncol 23:2145-2154, 2005 (Pubitemid 46218706)
-
(2005)
Journal of Clinical Oncology
, vol.23
, Issue.10
, pp. 2145-2154
-
-
Movsas, B.1
Scott, C.2
Langer, C.3
Werner-Wasik, M.4
Nicolaou, N.5
Komaki, R.6
Machtay, M.7
Smith, C.8
Axelrod, R.9
Sarna, L.10
Wasserman, T.11
Byhardt, R.12
-
36
-
-
56349137675
-
Clinically meaningful differences in patient-reported outcomes with amifostine in combination with chemoradiation for locally advanced non-small-cell lung cancer: An analysis of RTOG 9801
-
Sarna L, Swann S, Langer C, et al: Clinically meaningful differences in patient-reported outcomes with amifostine in combination with chemoradiation for locally advanced non-small-cell lung cancer: An analysis of RTOG 9801. Int J Radiat Oncol Biol Phys 72:1378-1384, 2008
-
(2008)
Int J Radiat Oncol Biol Phys
, vol.72
, pp. 1378-1384
-
-
Sarna, L.1
Swann, S.2
Langer, C.3
-
37
-
-
73349122621
-
Quality of life supersedes the classic prognosticators for long-term survival in locally advanced non-small-cell lung cancer: An analysis of RTOG 9801
-
Movsas B, Moughan J, Sarna L, et al: Quality of life supersedes the classic prognosticators for long-term survival in locally advanced non-small-cell lung cancer: An analysis of RTOG 9801. J Clin Oncol 27:5816-5822, 2009
-
(2009)
J Clin Oncol
, vol.27
, pp. 5816-5822
-
-
Movsas, B.1
Moughan, J.2
Sarna, L.3
-
38
-
-
21044453902
-
Randomized phase III study of matrix metalloproteinase inhibitor BMS-275291 in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: National Cancer Institute of Canada-Clinical Trials Group Study BR. 18
-
DOI 10.1200/JCO.2005.04.044
-
Leighl NB, Paz-Ares L, Douillard JY, et al: Randomized phase III study of matrix metalloproteinase inhibitor BMS-275291 in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: National Cancer Institute of Canada-Clinical Trials Group Study BR. 18. J Clin Oncol 23:2831-2839, 2005 (Pubitemid 46179474)
-
(2005)
Journal of Clinical Oncology
, vol.23
, Issue.12
, pp. 2831-2839
-
-
Leighl, N.B.1
Paz-Ares, L.2
Douillard, J.-Y.3
Peschel, C.4
Arnold, A.5
Depierre, A.6
Santoro, A.7
Betticher, D.C.8
Gatzemeier, U.9
Jassem, J.10
Crawford, J.11
Tu, D.12
Bezjak, A.13
Humphrey, J.S.14
Voi, M.15
Galbraith, S.16
Hann, K.17
Seymour, L.18
Shepherd, F.A.19
-
39
-
-
20944436114
-
Gemcitabine-docetaxel versus cisplatin-vinorelbine in advanced or metastatic non-small-cell lung cancer: A phase III study addressing the case for cisplatin
-
DOI 10.1093/annonc/mdi126
-
Pujol JL, Breton JL, Gervais R, et al: Gemcitabine-docetaxel versus cisplatin-vinorelbine in advanced or metastatic non-small-cell lung cancer: A phase III study addressing the case for cisplatin. Ann Oncol 16:602-610, 2005 (Pubitemid 40613327)
-
(2005)
Annals of Oncology
, vol.16
, Issue.4
, pp. 602-610
-
-
Pujol, J.-L.1
Breton, J.-L.2
Gervais, R.3
Rebattu, P.4
Depierre, A.5
Morere, J.-F.6
Milleron, B.7
Debieuvre, D.8
Castera, D.9
Souquet, P.-J.10
Moro-Sibilot, D.11
Lemarie, E.12
Kessler, R.13
Janicot, H.14
Braun, D.15
Spaeth, D.16
Quantin, X.17
Clary, C.18
-
40
-
-
20444364830
-
Immediate or delayed radiotherapy in advanced non-small cell lung cancer (NSCLC)? Data from a prospective randomised study
-
DOI 10.1016/j.radonc.2005.03.028, PII S0167814005001271
-
Sundstrøm S, Bremnes R, Brunsvig P, et al: Immediate or delayed radiotherapy in advanced nonsmall cell lung cancer (NSCLC)? Data from a prospective randomised study. Radiother Oncol 75: 141-148, 2005 (Pubitemid 40805242)
-
(2005)
Radiotherapy and Oncology
, vol.75
, Issue.2
, pp. 141-148
-
-
Sundstrom, S.1
Bremnes, R.2
Brunsvig, P.3
Aasebo, U.4
Klepp, O.5
Fayers, P.M.6
Kaasa, S.7
-
41
-
-
1542713367
-
Hypofractionated palliative radiotherapy (17 Gy per two fractions) in advanced non-small-cell lung carcinoma is comparable to standard fractionation for symptom control and survival: A national phase III trial
-
DOI 10.1200/JCO.2004.06.123
-
Sundstrøm S, Bremnes R, Aasebø U, et al: Hypofractionated palliative radiotherapy (17 Gy per two fractions) in advanced non-small-cell lung carcinoma is comparable to standard fractionation for symptom control and survival: A national phase III trial. J Clin Oncol 22:801-810, 2004 (Pubitemid 41103591)
-
(2004)
Journal of Clinical Oncology
, vol.22
, Issue.5
, pp. 801-810
-
-
Sundstrom, S.1
Bremnes, R.2
Aasebo, U.3
Aamdal, S.4
Hatlevoll, R.5
Brunsvig, P.6
Johannessen, D.C.7
Klepp, O.8
Fayers, P.M.9
Kaasa, S.10
-
42
-
-
21144437547
-
Vinorelbine plus cisplatin versus docetaxel plus gemcitabine in advanced non-small-cell lung cancer: A phase III randomized trial
-
DOI 10.1200/JCO.2005.04.016
-
Georgoulias V, Ardavanis A, Tsiafaki X, et al: Vinorelbine plus cisplatin versus docetaxel plus gemcitabine in advanced non-small-cell lung cancer: A phase III randomized trial. J Clin Oncol 23:2937-2945, 2005 (Pubitemid 46224112)
-
(2005)
Journal of Clinical Oncology
, vol.23
, Issue.13
, pp. 2937-2945
-
-
Georgoulias, V.1
Ardavanis, A.2
Tsiafaki, X.3
Agelidou, A.4
Mixalopoulou, P.5
Anagnostopoulou, O.6
Ziotopoulos, P.7
Toubis, M.8
Syrigos, K.9
Samaras, N.10
Polyzos, A.11
Christou, A.12
Kakolyris, S.13
Kouroussis, C.14
Androulakis, N.15
Samonis, G.16
Chatzidaki, D.17
-
43
-
-
25444511051
-
Randomized phase III trial comparing cisplatin-etoposide to carboplatin-paclitaxel in advanced or metastatic non-small cell lung cancer
-
DOI 10.1093/annonc/mdi216
-
Belani CP, Lee JS, Socinski MA, et al: Randomized phase III trial comparing cisplatin-etoposide to carboplatin-paclitaxel in advanced or metastatic non-small cell lung cancer. Ann Oncol 16:1069-1075, 2005 (Pubitemid 41418307)
-
(2005)
Annals of Oncology
, vol.16
, Issue.7
, pp. 1069-1075
-
-
Belani, C.P.1
Lee, J.S.2
Socinski, M.A.3
Robert, F.4
Waterhouse, D.5
Rowland, K.6
Ansari, R.7
Lilenbaum, R.8
Natale, R.B.9
-
44
-
-
33644684204
-
Phase III trial of gemcitabine plus carboplatin versus single-agent gemcitabine in the treatment of locally advanced or metastatic non-small-cell lung cancer: The Swedish Lung Cancer Study Group
-
Sederholm C, Hillerdal G, Lamberg K, et al: Phase III trial of gemcitabine plus carboplatin versus single-agent gemcitabine in the treatment of locally advanced or metastatic non-small-cell lung cancer: The Swedish Lung Cancer Study Group. J Clin Oncol 23:8380-8388, 2005
-
(2005)
J Clin Oncol
, vol.23
, pp. 8380-8388
-
-
Sederholm, C.1
Hillerdal, G.2
Lamberg, K.3
-
45
-
-
29844433092
-
A randomized phase II trial comparing every 3-weeks carboplatin/ paclitaxel with every 3-weeks carboplatin and weekly paclitaxel in advanced non-small cell lung cancer
-
DOI 10.1093/annonc/mdj016
-
Socinski MA, Ivanova A, Bakri K, et al: A randomized phase II trial comparing every 3-weeks carboplatin/paclitaxel with every 3-weeks carboplatin and weekly paclitaxel in advanced non-small cell lung cancer. Ann Oncol 17:104-109, 2006 (Pubitemid 43033848)
-
(2006)
Annals of Oncology
, vol.17
, Issue.1
, pp. 104-109
-
-
Socinski, M.A.1
Ivanova, A.2
Bakri, K.3
Wall, J.4
Baggstrom, M.Q.5
Hensing, T.A.6
Mears, A.7
Tynan, M.8
Beaumont, J.9
Peterman, A.H.10
Niell, H.B.11
-
46
-
-
33745632406
-
A phase III trial of docetaxel/carboplatin versus mitomycin C/ifosfamide/ cisplatin (MIC) or mitomycin C/vinblastine/cisplatin (MVP) in patients with advanced non-small-cell lung cancer: A randomised multicentre trial of the British Thoracic Oncology Group (BTOG1)
-
DOI 10.1093/annonc/mdl078
-
Booton R, Lorigan P, Anderson H, et al: A phase III trial of docetaxel/carboplatin versus mitomycin C/ifosfamide/cisplatin (MIC) or mitomycin C/vinblastine/cisplatin (MVP) in patients with advanced non-small-cell lung cancer: A randomized multicentre trial of the British Thoracic Oncology Group (BTOG1). Ann Oncol 17:1111-1119, 2006 (Pubitemid 43985247)
-
(2006)
Annals of Oncology
, vol.17
, Issue.7
, pp. 1111-1119
-
-
Booton, R.1
Lorigan, P.2
Anderson, H.3
Baka, S.4
Ashcroft, L.5
Nicolson, M.6
O'Brien, M.7
Dunlop, D.8
O'Byrne, K.9
Laurence, V.10
Snee, M.11
Dark, G.12
Thatcher, N.13
-
47
-
-
33747080816
-
Phase III study of docetaxel compared with vinorelbine in elderly patients with advanced non-small-cell lung cancer: Results of the West Japan Thoracic Oncology Group trial (WJTOG 9904)
-
DOI 10.1200/JCO.2006.06.1044
-
Kudoh S, Takeda K, Nakagawa K, et al: Phase III study of docetaxel compared with vinorelbine in elderly patients with advanced non-small-cell lung cancer: Results of the West Japan Thoracic Oncology Group Trial (WJTOG 9904). J Clin Oncol 24: 3657-3663, 2006 (Pubitemid 46630541)
-
(2006)
Journal of Clinical Oncology
, vol.24
, Issue.22
, pp. 3657-3663
-
-
Kudoh, S.1
Takeda, K.2
Nakagawa, K.3
Takada, M.4
Katakami, N.5
Matsui, K.6
Shinkai, T.7
Sawa, T.8
Goto, I.9
Semba, H.10
Seto, T.11
Ando, M.12
Satoh, T.13
Yoshimura, N.14
Negoro, S.15
Fukuoka, M.16
-
48
-
-
33750207905
-
Palliative chemotherapy beyond three courses conveys no survival or consistent quality-of-life benefits in advanced non-small-cell lung cancer
-
DOI 10.1038/sj.bjc.6603383, PII 6603383
-
von Plessen C, Berman B, Andresen O, et al: Palliative chemotherapy beyond three courses conveys no survival or consistent quality-of-life benefits in advanced non-small-cell lung cancer. Br J Cancer 95:966-973, 2006 (Pubitemid 44606820)
-
(2006)
British Journal of Cancer
, vol.95
, Issue.8
, pp. 966-973
-
-
Von Plessen, C.1
Bergman, B.2
Andresen, O.3
Bremnes, R.M.4
Sundstrom, S.5
Gilleryd, M.6
Stephens, R.7
Vilsvik, J.8
Aasebo, U.9
Sorenson, S.10
-
49
-
-
33847408454
-
Open, randomized, phase II study of single-agent gemcitabine and docetaxel as first- and second-line treatment in patients with advanced non-small-cell lung cancer
-
Manegold C, Koschel G, Hruska D, et al: Open, randomized, phase II study of single-agent gemcitabine and docetaxel as first- and second-line treatment in patients with advanced non-small-cell lung cancer. Clin Lung Cancer 8:245-251, 2007 (Pubitemid 46333569)
-
(2007)
Clinical Lung Cancer
, vol.8
, Issue.4
, pp. 245-251
-
-
Manegold, C.1
Koschel, G.2
Hruska, D.3
Schott-von-Romer, K.4
Mezger, J.5
Pilz, L.R.6
-
50
-
-
33847276516
-
Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan
-
DOI 10.1093/annonc/mdl377
-
Ohe Y, Ohashi Y, Kubota K, et al: Randomized phase III study of cisplatin plus irinotecan versus carboplatin plus paclitaxel, cisplatin plus gemcitabine, and cisplatin plus vinorelbine for advanced non-small-cell lung cancer: Four-Arm Cooperative Study in Japan. Ann Oncol 18:317-323, 2007 (Pubitemid 46323100)
-
(2007)
Annals of Oncology
, vol.18
, Issue.2
, pp. 317-323
-
-
Ohe, Y.1
Ohashi, Y.2
Kubota, K.3
Tamura, T.4
Nakagawa, K.5
Negoro, S.6
Nishiwaki, Y.7
Saijo, N.8
Ariyoshi, Y.9
Fukuoka, M.10
-
51
-
-
33847283017
-
Impact of hemoglobin levels on outcomes of adjuvant chemotherapy in resected non-small cell lung cancer: The JBR.10 trial experience
-
DOI 10.1016/j.lungcan.2006.10.021, PII S016950020600599X
-
Gauthier I, Ding K, Winton T, et al: Impact of hemoglobin levels on outcomes of adjuvant chemotherapy in resected non-small cell lung cancer: The JBR.10 trial experience. Lung Cancer 55:357-363, 2007 (Pubitemid 46329181)
-
(2007)
Lung Cancer
, vol.55
, Issue.3
, pp. 357-363
-
-
Gauthier, I.1
Ding, K.2
Winton, T.3
Shepherd, F.A.4
Livingston, R.5
Johnson, D.H.6
Rigas, J.R.7
Whitehead, M.8
Graham, B.9
Seymour, L.10
-
52
-
-
55649089263
-
Quality-of-life outcomes for adjuvant chemotherapy in early-stage non-small-cell lung cancer: Results from a randomized trial, JBR.10
-
Bezjak A, Lee CW, Ding K, et al: Quality-of-life outcomes for adjuvant chemotherapy in early-stage non-small-cell lung cancer: Results from a randomized trial, JBR.10. J Clin Oncol 26:5052-5059, 2008
-
(2008)
J Clin Oncol
, vol.26
, pp. 5052-5059
-
-
Bezjak, A.1
Lee, C.W.2
Ding, K.3
-
53
-
-
20544455590
-
Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer
-
DOI 10.1056/NEJMoa043623
-
Winton T, Livingston R, Johnson D, et al: Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer. N Engl J Med 352:2589-2597, 2005 (Pubitemid 41007845)
-
(2005)
New England Journal of Medicine
, vol.352
, Issue.25
, pp. 2589-2597
-
-
Winton, T.1
Livingston, R.2
Johnson, D.3
Rigas, J.4
Johnston, M.5
Butts, C.6
Cormier, Y.7
Goss, G.8
Inculet, R.9
Vallieres, E.10
Fry, W.11
Bethune, D.12
Ayoub, J.13
Ding, K.14
Seymour, L.15
Graham, B.16
Tsao, M.-S.17
Gandara, D.18
Kesler, K.19
Demmy, T.20
Shepherd, F.21
more..
-
54
-
-
34247106263
-
A randomized trial comparing immediate versus delayed treatment of anemia with once-weekly epoetin alfa in patients with non-small cell lung cancer Scheduled to Receive First-Line Chemotherapy
-
DOI 10.1097/JTO.0b013e318031cd9a, PII 0124389420070300000008
-
Crawford J, Robert F, Perry MC, et al: A randomized trial comparing immediate versus delayed treatment of anemia with once-weekly epoetin alfa in patients with non-small cell lung cancer scheduled to receive first-line chemotherapy. J Thorac Oncol 2:210-220, 2007 (Pubitemid 47181326)
-
(2007)
Journal of Thoracic Oncology
, vol.2
, Issue.3
, pp. 210-220
-
-
Crawford, J.1
Robert, F.2
Perry, M.C.3
Belani, C.4
Williams, D.5
-
55
-
-
34247154396
-
A randomized phase II trial of single-agent gemcitabine, vinorelbine, or docetaxel in patients with advanced non-small cell lung cancer who have poor performance status and/or are elderly
-
DOI 10.1097/JTO.0b013e318031d06f, PII 0124389420070300000010
-
Leong SS, Toh CK, Lim WT, et al: A randomized phase II trial of single-agent gemcitabine, vinorelbine, or docetaxel in patients with advanced non-small cell lung cancer who have poor performance status and/or are elderly. J Thorac Oncol 2:230-236, 2007 (Pubitemid 47181328)
-
(2007)
Journal of Thoracic Oncology
, vol.2
, Issue.3
, pp. 230-236
-
-
Leong, S.S.1
Toh, C.K.2
Lim, W.T.3
Lin, X.4
Tan, S.B.5
Poon, D.6
Tay, M.H.7
Foo, K.F.8
Ho, J.9
Tan, E.H.10
-
56
-
-
34247877762
-
A randomized phase II trial of two schedules of docetaxel in elderly or poor performance status patients with advanced non-small cell lung cancer
-
DOI 10.1097/01.JTO.0000263713.38826.8e, PII 0124389420070400000010
-
Lilenbaum R, Rubin M, Samuel J, et al: A randomized phase II trial of two schedules of docetaxel in elderly or poor performance status patients with advanced non-small cell lung cancer. J Thorac Oncol 2:306-311, 2007 (Pubitemid 47181713)
-
(2007)
Journal of Thoracic Oncology
, vol.2
, Issue.4
, pp. 306-311
-
-
Lilenbaum, R.1
Rubin, M.2
Samuel, J.3
Boros, L.4
Chidiac, T.5
Seigel, L.6
Dowlati, A.7
Graham, P.8
Beaumont, J.9
Du, H.10
-
57
-
-
34248140107
-
Phase III study of erlotinib in combination with cisplatin and gemcitabine in advanced non-small-cell lung cancer: The Tarceva lung cancer investigation trial
-
DOI 10.1200/JCO.2005.05.1474
-
Gatzemeier U, Pluzanska A, Szczesna A, et al: Phase III study of erlotinib in combination with cisplatin and gemcitabine in advanced non-small-cell lung cancer: The Tarceva Lung Cancer Investigation Trial. J Clin Oncol 25:1545-1552, 2007 (Pubitemid 46733081)
-
(2007)
Journal of Clinical Oncology
, vol.25
, Issue.12
, pp. 1545-1552
-
-
Gatzemeier, U.1
Pluzanska, A.2
Szczesna, A.3
Kaukel, E.4
Roubec, J.5
De Rosa, F.6
Milanowski, J.7
Karnicka-Mlodkowski, H.8
Pesek, M.9
Serwatowski, P.10
Ramlau, R.11
Janaskova, T.12
Vansteenkiste, J.13
Strausz, J.14
Manikhas, G.M.15
Von Pawel, J.16
-
58
-
-
34249320128
-
Factorial phase III randomised trial of rofecoxib and prolonged constant infusion of gemcitabine in advanced non-small-cell lung cancer: The GEmcitabine-COxib in NSCLC (GECO) study
-
DOI 10.1016/S1470-2045(07)70146-8, PII S1470204507701468
-
Gridelli C, Gallo C, Ceribelli A, et al: Factorial phase III randomised trial of rofecoxib and prolonged constant infusion of gemcitabine in advanced nonsmall-cell lung cancer: The GEmcitabine-COxib in NSCLC (GECO) study. Lancet Oncol 8:500-512, 2007 (Pubitemid 46805905)
-
(2007)
Lancet Oncology
, vol.8
, Issue.6
, pp. 500-512
-
-
Gridelli, C.1
Gallo, C.2
Ceribelli, A.3
Gebbia, V.4
Gamucci, T.5
Ciardiello, F.6
Carozza, F.7
Favaretto, A.8
Daniele, B.9
Galetta, D.10
Barbera, S.11
Rosetti, F.12
Rossi, A.13
Maione, P.14
Cognetti, F.15
Testa, A.16
Di Maio, M.17
Morabito, A.18
Perrone, F.19
-
59
-
-
34249866544
-
Preoperative chemotherapy in patients with resectable non-small cell lung cancer: results of the MRC LU22/NVALT 2/EORTC 08012 multicentre randomised trial and update of systematic review
-
DOI 10.1016/S0140-6736(07)60714-4, PII S0140673607607144
-
Gilligan D, Nicolson M, Smith I, et al: Preoperative chemotherapy in patients with respectable non-small cell lung cancer: Results of the MRC LU22/NVALT 2/EORTC 08012 multicentre randomized trial and update of systematic review. Lancet 369:1929-1937, 2007 (Pubitemid 46874559)
-
(2007)
Lancet
, vol.369
, Issue.9577
, pp. 1929-1937
-
-
Gilligan, D.1
Nicolson, M.2
Smith, I.3
Groen, H.4
Dalesio, O.5
Goldstraw, P.6
Hatton, M.7
Hopwood, P.8
Manegold, C.9
Schramel, F.10
Smit, H.11
Van Meerbeeck, J.12
Nankivell, M.13
Parmar, M.14
Pugh, C.15
Stephens, R.16
-
60
-
-
34547561744
-
Vinorelbine/carboplatin vs gemcitabine/carboplatin in advanced NSCLC shows similar efficacy, but different impact of toxicity
-
DOI 10.1038/sj.bjc.6603869, PII 6603869
-
Helbekkmo N, Sundstrøm SH, Aasebø U, et al: Vinorelbine/carboplatin vs gemcitabine/carboplatin in advanced NSCLC shows similar efficacy, but different impact of toxicity. Br J Cancer 97:283-289, 2007 (Pubitemid 47196742)
-
(2007)
British Journal of Cancer
, vol.97
, Issue.3
, pp. 283-289
-
-
Helbekkmo, N.1
Sundstrom, S.H.2
Aasebo, U.3
Fr Brunsvig, P.4
Von Plessen, C.5
Hjelde, H.H.6
Garpestad, O.K.7
Bailey, A.8
Bremnes, R.M.9
-
61
-
-
36849019938
-
Phase III trial of two versus four additional cycles in patients who are nonprogressive after two cycles of platinumbased chemotherapy in non-small-cell lung cancer
-
Park JO, Kim SW, Ahn JS, et al: Phase III trial of two versus four additional cycles in patients who are nonprogressive after two cycles of platinumbased chemotherapy in non-small-cell lung cancer. J Clin Oncol 25:5233-5239, 2007
-
(2007)
J Clin Oncol
, vol.25
, pp. 5233-5239
-
-
Park, J.O.1
Kim, S.W.2
Ahn, J.S.3
-
62
-
-
37549069291
-
Docetaxel versus docetaxel plus gemcitabine as front-line treatment of patients with advanced nonsmall cell lung cancer: A randomized, multicenter phase III trial
-
Georgoulias V, Androulakis N, Kotsakis A, et al: Docetaxel versus docetaxel plus gemcitabine as front-line treatment of patients with advanced nonsmall cell lung cancer: A randomized, multicenter phase III trial. Lung Cancer 59:57-63, 2008
-
(2008)
Lung Cancer
, vol.59
, pp. 57-63
-
-
Georgoulias, V.1
Androulakis, N.2
Kotsakis, A.3
-
63
-
-
39749087795
-
Randomized phase II trial of erlotinib or standard chemotherapy in patients with advanced non-small-cell lung cancer and a performance status of 2
-
DOI 10.1200/JCO.2007.13.2720
-
Lilenbaum R, Axelrod R, Thomas S, et al: Randomized phase II trial of erlotinib or standard chemotherapy in patients with advanced non-smallcell lung cancer and a performance status of 2. J Clin Oncol 26:863-869, 2008 (Pubitemid 351398077)
-
(2008)
Journal of Clinical Oncology
, vol.26
, Issue.6
, pp. 863-869
-
-
Lilenbaum, R.1
Axelrod, R.2
Thomas, S.3
Dowlati, A.4
Seigel, L.5
Albert, D.6
Witt, K.7
Botkin, D.8
-
64
-
-
42949170958
-
Phase III randomized, double-blind study of maintenance CAI or placebo in patients with advanced non-small cell lung cancer (NSCLC) after completion of initial therapy (NCCTG 97-24-51)
-
DOI 10.1016/j.lungcan.2007.10.003, PII S0169500207006071
-
Johnson EA, Marks RS, Mandrekar SJ, et al: Phase III randomized, double-blind study of maintenance CAI or placebo in patients with advanced non-small cell lung cancer (NSCLC) after completion of initial therapy (NCCTG 97-24-51). Lung Cancer 60:200-207, 2008 (Pubitemid 351609147)
-
(2008)
Lung Cancer
, vol.60
, Issue.2
, pp. 200-207
-
-
Johnson, E.A.1
Marks, R.S.2
Mandrekar, S.J.3
Hillman, S.L.4
Hauge, M.D.5
Bauman, M.D.6
Wos, E.J.7
Moore, D.F.8
Kugler, J.W.9
Windschitl, H.E.10
Graham, D.L.11
Bernath Jr., A.M.12
Fitch, T.R.13
Soori, G.S.14
Jett, J.R.15
Adjei, A.A.16
Perez, E.A.17
-
65
-
-
67249163661
-
Evaluation of glutathione metabolic genes on outcomes in advanced non-small cell lung cancer patients after initial treatment with platinum-based chemotherapy: An NCCTG-97-24-51 based study
-
Yang P, Mandrekar SJ, Hillman SH, et al: Evaluation of glutathione metabolic genes on outcomes in advanced non-small cell lung cancer patients after initial treatment with platinum-based chemotherapy: An NCCTG-97-24-51 based study. J Thorac Oncol 4:479-485, 2009
-
(2009)
J Thorac Oncol
, vol.4
, pp. 479-485
-
-
Yang, P.1
Mandrekar, S.J.2
Hillman, S.H.3
-
66
-
-
52049096854
-
Gefitinib versus vinorelbine in chemotherapy-naïve elderly patients with advanced non-small-cell lung cancer (INVITE): Randomized, phase II study
-
Crinò L, Cappuzzo F, Zatloukal P, et al: Gefitinib versus vinorelbine in chemotherapy-naïve elderly patients with advanced non-small-cell lung cancer (INVITE): Randomized, phase II study. J Clin Oncol 26:4253-4260, 2008
-
(2008)
J Clin Oncol
, vol.26
, pp. 4253-4260
-
-
Crinò, L.1
Cappuzzo, F.2
Zatloukal, P.3
-
67
-
-
51049116840
-
Cisplatin plus weekly vinorelbine versus cisplatin plus vinorelbine on days 1 and 8 in advanced non-small cell lung cancer: A prospective randomized phase III trial of the G.O.C.I.M. (Gruppo Oncologico Italia Meridionale)
-
Gebbia V, Galetta D, Lorusso V, et al: Cisplatin plus weekly vinorelbine versus cisplatin plus vinorelbine on days 1 and 8 in advanced non-small cell lung cancer: A prospective randomized phase III trial of the G.O.C.I.M. (Gruppo Oncologico Italia Meridionale). Lung Cancer 61:369-377, 2008
-
(2008)
Lung Cancer
, vol.61
, pp. 369-377
-
-
Gebbia, V.1
Galetta, D.2
Lorusso, V.3
-
68
-
-
59149092945
-
Phase III study of immediate compared with delayed docetaxel after front-line therapy with gemcitabine plus carboplatin in advanced non-small-cell lung cancer
-
Fidias PM, Dakhil SR, Lyss AP, et al: Phase III study of immediate compared with delayed docetaxel after front-line therapy with gemcitabine plus carboplatin in advanced non-small-cell lung cancer. J Clin Oncol 27:591-598, 2009
-
(2009)
J Clin Oncol
, vol.27
, pp. 591-598
-
-
Fidias, P.M.1
Dakhil, S.R.2
Lyss, A.P.3
-
69
-
-
67349140361
-
How to improve loco-regional control in stages IIIa-b NSCLC? Results of a three-armed randomized trial from the Swedish Lung Cancer Study Group
-
Nyman J, Friesland S, Hallqvist A, et al: How to improve loco-regional control in stages IIIa-b NSCLC? Results of a three-armed randomized trial from the Swedish Lung Cancer Study Group. Lung Cancer 65:62-67, 2009
-
(2009)
Lung Cancer
, vol.65
, pp. 62-67
-
-
Nyman, J.1
Friesland, S.2
Hallqvist, A.3
-
70
-
-
67650281462
-
Phase III study by the Norwegian lung cancer study group: Pemetrexed plus carboplatin compared with gemcitabine plus carboplatin as first-line chemotherapy in advanced non-small-cell lung cancer
-
Grønberg BH, Bremnes RM, Fløtten O, et al: Phase III study by the Norwegian lung cancer study group: Pemetrexed plus carboplatin compared with gemcitabine plus carboplatin as first-line chemotherapy in advanced non-small-cell lung cancer. J Clin Oncol 27:3217-3224, 2009
-
(2009)
J Clin Oncol
, vol.27
, pp. 3217-3224
-
-
Grønberg, B.H.1
Bremnes, R.M.2
Fløtten, O.3
-
71
-
-
69549116226
-
Gemcitabine in brief versus prolonged low-dose infusion, both combined with cisplatin, for advanced nonsmall cell lung cancer: A randomized phase II clinical trial
-
Zwitter M, Kovac V, Smrdel U, et al: Gemcitabine in brief versus prolonged low-dose infusion, both combined with cisplatin, for advanced nonsmall cell lung cancer: A randomized phase II clinical trial. J Thorac Oncol 4:1148-1155, 2009
-
(2009)
J Thorac Oncol
, vol.4
, pp. 1148-1155
-
-
Zwitter, M.1
Kovac, V.2
Smrdel, U.3
-
72
-
-
70449720894
-
Randomized double-blind placebo-controlled trial of thalidomide in combination with gemcitabine and carboplatin in advanced non-small-cell lung cancer
-
Lee SM, Rudd R, Woll PJ, et al: Randomized double-blind placebo-controlled trial of thalidomide in combination with gemcitabine and carboplatin in advanced non-small-cell lung cancer. J Clin Oncol 27:5248-5254, 2009
-
(2009)
J Clin Oncol
, vol.27
, pp. 5248-5254
-
-
Lee, S.M.1
Rudd, R.2
Woll, P.J.3
-
73
-
-
77649203360
-
Randomized phase III trial of platinum-doublet chemotherapy followed by gefitinib compared with continued platinum-doublet chemotherapy in Japanese patients with advanced non-small cell lung cancer: Results of a west Japan thoracic oncology group trial (WJTOG0203)
-
Takeda K, Hilda T, Sato T, et al: Randomized phase III trial of platinum-doublet chemotherapy followed by gefitinib compared with continued platinum-doublet chemotherapy in Japanese patients with advanced non-small cell lung cancer: Results of a west Japan thoracic oncology group trial (WJTOG0203). J Clin Oncol 28:753-760, 2010
-
(2010)
J Clin Oncol
, vol.28
, pp. 753-760
-
-
Takeda, K.1
Hilda, T.2
Sato, T.3
-
74
-
-
77949891126
-
Cetuximab and first-line taxane/carboplatin chemotherapy in advanced non-small-cell lung cancer: Results of the randomized multicenter phase III trial BMS099
-
Lynch TJ, Patel T, Dreisbach L, et al: Cetuximab and first-line taxane/carboplatin chemotherapy in advanced non-small-cell lung cancer: Results of the randomized multicenter phase III trial BMS099. J Clin Oncol 28:911-917, 2010
-
(2010)
J Clin Oncol
, vol.28
, pp. 911-917
-
-
Lynch, T.J.1
Patel, T.2
Dreisbach, L.3
-
75
-
-
77953539831
-
Two schedules of chemotherapy for patients with nonsmall cell lung cancer in poor performance status: A phase II randomized trial
-
Zwitter M, Kovac V, Rajer M, et al: Two schedules of chemotherapy for patients with nonsmall cell lung cancer in poor performance status: A phase II randomized trial. Anticancer Drugs 21:662-668, 2010
-
(2010)
Anticancer Drugs
, vol.21
, pp. 662-668
-
-
Zwitter, M.1
Kovac, V.2
Rajer, M.3
-
76
-
-
0027417437
-
The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology
-
Aaronson NK, Ahmedzai S, Bergman B, et al: The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365-376, 1993 (Pubitemid 23073154)
-
(1993)
Journal of the National Cancer Institute
, vol.85
, Issue.5
, pp. 365-376
-
-
Aaronson, N.K.1
Ahmedzai, S.2
Bergman, B.3
Bullinger, M.4
Cull, A.5
Duez, N.J.6
Filiberti, A.7
Flechtner, H.8
Fleishman, S.B.9
De Haes, J.C.J.M.10
Kaasa, S.11
Klee, M.12
Osoba, D.13
Razavi, D.14
Rofe, P.B.15
Schraub, S.16
Sneeuw, K.17
Sullivan, M.18
Takeda, F.19
-
77
-
-
0028275927
-
The EORTC QLQ-LC13: A modular supplement to the EORTC core quality of life questionnaire (QLQ-C30) for use in lung cancer clinical trials
-
DOI 10.1016/0959-8049(94)90535-5
-
Bergman B, Aaronson NK, Ahmedzai S, et al: The EORTC QLQ-LC13: A modular supplement to the EORTC Core Quality of Life Questionnaire (QLQC30) for use in lung cancer clinical trials-EORTC Study Group on Quality of Life. Eur J Cancer 30A: 635-642, 1994 (Pubitemid 24164250)
-
(1994)
European Journal of Cancer Part A: General Topics
, vol.30
, Issue.5
, pp. 635-642
-
-
Bergman, B.1
Aaronson, N.K.2
Ahmedzai, S.3
Kaasa, S.4
Sullivan, M.5
-
78
-
-
0028471807
-
Quality of life during clinical trials: Conceptual model for the lung cancer symptom score (LCSS)
-
Hollen PJ, Gralla RJ, Kris RG, et al: Quality of life during clinical trials: Conceptual model for the lung cancer symptom score (LCSS). Support Care Cancer 2:213-222, 1994
-
(1994)
Support Care Cancer
, vol.2
, pp. 213-222
-
-
Hollen, P.J.1
Gralla, R.J.2
Kris, R.G.3
-
79
-
-
0028267598
-
Measurement of quality of life in patients with lung cancer in multicenter trials of new therapies: Psychometric assessment of the lung cancer symptom scale
-
Hollen PJ, Gralla RJ, Kris MG, et al: Measurement of quality of life in patients with lung cancer in multicenter trials of new therapies: Psychometric assessment of the Lung Cancer Symptom Scale. Cancer 73:2087-2098, 1994 (Pubitemid 24107963)
-
(1994)
Cancer
, vol.73
, Issue.8
, pp. 2087-2098
-
-
Hollen, P.J.1
Gralla, R.J.2
Kris, M.G.3
Cox, C.4
Belani, C.P.5
Grunberg, S.M.6
Crawford, J.7
Neidhart, J.A.8
-
80
-
-
0027407786
-
The functional assessment of cancer therapy scale: Development and validation of the general measure
-
Cella DF, Tulsky DS, Gray G, et al: The functional assessment of cancer therapy scale: Development and validation of the general measure. J Clin Oncol 11:570-579, 1993 (Pubitemid 23071057)
-
(1993)
Journal of Clinical Oncology
, vol.11
, Issue.3
, pp. 570-579
-
-
Cella, D.F.1
Tulsky, D.S.2
Gray, G.3
Sarafian, B.4
Linn, E.5
Bonomi, A.6
Silberman, M.7
Yellen, S.B.8
Winicour, P.9
Brannon, J.10
Eckberg, K.11
Lloyd, S.12
Purl, S.13
Blendowski, C.14
Goodman, M.15
Barnicle, M.16
Stewart, I.17
McHale, M.18
Bonomi, P.19
-
81
-
-
0025639135
-
Measuring psychological and physical distress in cancer patients: Structure and application of the Rotterdam symptom checklist
-
de Haes JCJM, van Knipperberg FCE, Neijt JP: Measuring psychological and physical distress in cancer patients: Structure and application of the Rotterdam symptom checklist. Br J Cancer 62:1034-1038, 1990
-
(1990)
Br J Cancer
, vol.62
, pp. 1034-1038
-
-
De Haes, J.C.J.M.1
Van Knipperberg, F.C.E.2
Neijt, J.P.3
-
82
-
-
0033006597
-
The rapid assessment of fatigue severity in cancer patients: Use of the brief fatigue inventory
-
DOI 10.1002/(SICI)1097-0142(19990301)85:5<1186::AID-CNCR24>3.0. CO;2-N
-
Mendoza TR, Wang XS, Cleeland CS, et al: The rapid assessment of fatigue severity in cancer patients: Use of the Brief Fatigue Inventory. Cancer 85:1186-1196, 1999 (Pubitemid 29115600)
-
(1999)
Cancer
, vol.85
, Issue.5
, pp. 1186-1196
-
-
Mendoza, T.R.1
Wang, X.S.2
Cleeland, C.S.3
Morrissey, M.4
Johnson, B.A.5
Wendt, J.K.6
Huber, S.L.7
-
83
-
-
0029952658
-
EuroQol: The current state of play
-
DOI 10.1016/0168-8510(96)00822-6
-
Brooks R: EuroQol: The current state of play. Health Policy 37:53-72, 1996 (Pubitemid 26191458)
-
(1996)
Health Policy
, vol.37
, Issue.1
, pp. 53-72
-
-
Brooks, R.1
De Charro, F.2
-
84
-
-
36349008586
-
Validation of Single-Item Linear Analog Scale Assessment of Quality of Life in Neuro-Oncology Patients
-
DOI 10.1016/j.jpainsymman.2007.01.016, PII S0885392407004630
-
Locke DEC, Decker PA, Sloan JA, et al: Validation of single-item Linear Analog Scale Assessment of quality of life in neuro-oncology patients. J Pain Symptom Manage 34:628-638, 2007 (Pubitemid 350161248)
-
(2007)
Journal of Pain and Symptom Management
, vol.34
, Issue.6
, pp. 628-638
-
-
Locke, D.E.C.1
Decker, P.A.2
Sloan, J.A.3
Brown, P.D.4
Malec, J.F.5
Clark, M.M.6
Rummans, T.A.7
Ballman, K.V.8
Schaefer, P.L.9
Buckner, J.C.10
-
85
-
-
0031972496
-
Interpreting the significance of changes in health-related quality-of- life scores
-
Osoba D, Rodrigues G, Myles J, et al: Interpreting the significance of changes in healthrelated quality-of-life scores. J Clin Oncol 16:139-144, 1998 (Pubitemid 28041591)
-
(1998)
Journal of Clinical Oncology
, vol.16
, Issue.1
, pp. 139-144
-
-
Osoba, D.1
Rodrigues, G.2
Myles, J.3
Zee, B.4
Pater, J.5
-
86
-
-
33748805503
-
Progress and problems for randomized clinical trials: From streptomycin to the era of megatrials
-
DOI 10.1093/eurheartj/ehl152
-
Hilbrich L, Sleight P: Progress and problems for randomized clinical trials: From streptomycin to the era of megatrials. Eur Heart J 27:2158-2164, 2006 (Pubitemid 44412828)
-
(2006)
European Heart Journal
, vol.27
, Issue.18
, pp. 2158-2164
-
-
Hilbrich, L.1
Sleight, P.2
|